Arkivoc 2019, v, 0-0
Kurokawa, N. et al.
Compound D-4 was obtained from D-3 in the same manner as L-4 (83 %). 1H-NMR (270 MHz, CDCl3) δ: 7.94 (2H,
d, J 7.4 Hz), 7.57 (1H, t, J 7.4 Hz), 7.44 (2H, t, J 7.4 Hz), 5.72 (1H, td, J 7.7, 3.8 Hz), 2.43 (2H, m), 2.23 (1H, m),
13
2
1.94 (3H, s), 1.87 (1H, m). C-NMR (67.8 MHz, CDCl3) δ: 196.3, 156.9 (q, JCF 37.6 Hz), 134.5, 133.3, 129.0,
128.7, 115.7 (q, JCF 287.8 Hz), 53.6, 32.4, 29.8, 15.3. [α]D -27.0 (c 1.0, CHCl3). HRMS-ESI (m/z) [M+Na]+ calcd
for C13H14F3NNaO2S+ 328.0590, found 328.0583.
1
(S)-2,2,2-Trifluoro-N-(4-(methylthio)-1-oxo-1-(p-tolyl)butan-2-yl)acetamide (L-9). To TFA-L-methionine-OSu L-
3 (57.5 mg, 0.168 mmol) in toluene (5, 5.4 ml, 1.01mmol), AlCl3 (1.07 g, 8.02 mmol) was added at rt. The
reaction mixture was stirred 40 min at rt and partitioned between water and EtOAc. The organic layer was
washed with H2O, NaHCO3, and brine, dried over MgSO4, filtered and concentrated. The residue was purified
by column chromatography (EtOAc: hexane = 1: 3) to give pale yellow solid (L)-9 (40.1 mg, 75 %). 1H-NMR (270
MHz, CDCl3) δ: 7.93 (2H, d, J 8.2 Hz), 7.71 (1H, br s), 7.33 (2H, d, J 8.2 Hz), 5.78 (1H, td, J 7.7, 3.7 Hz), 2.60-2.47
(2H, m), 2.44 (3H, s), 2.29 (1H, m), 2.04 (4H, s), 1.95 (1H, m). 13C-NMR (67.8 MHz, CDCl3) δ: 195.8, 156.9 (q, 2JCF
1
37.8 Hz), 145.8, 130.7, 129.7, 128.8, 115.7 (q, JCF 287.5 Hz), 53.5, 32.6, 29.8, 21.7, 15.4. [α]D +28.0 (c 1.0,
CHCl3). HRMS-ESI (m/z) [M+H]+ calcd for C14H17F3NO2S+ 320.0927, found 320.0925.
Compound D-9 was obtained from D-3 in the same manner as L-9 (71 %). 1H-NMR (270 MHz, CDCl3) δ: 7.92 (2H,
d, J 8.2 Hz), 7.58 (1H, br s), 7.34 (2H, d, J 8.2 Hz), 5.75 (1H, td, J 7.5, 4.1 Hz), 2.54 (2H, m), 2.45 (5H, s), 2.35-2.26
13
2
(1H, m), 2.04 (3H, s), 1.97 (1H, dd, J 13.8, 5.9 Hz). C-NMR (67.8 MHz, CDCl3) δ: 195.8, 157.0 (q, JCF 37.4 Hz),
145.9, 130.7, 129.9, 128.9, 115.7 (q, 1JCF 288.3 Hz), 53.5, 32.8, 29.8, 21.8, 15.5. [α]D -28.0 (c 1.0, CHCl3). HRMS-
ESI (m/z) [M+H]+ calcd for C14H17F3NO2S+ 320.0927, found 320.0922.
(S)-N-(1-(3,4-Dimethylphenyl)-4-(methylthio)-1-oxobutan-2-yl)-2,2,2-trifluoroacetamide (L-10). To TFA-L-
methionine-OSu L-3 (57.5 mg, 0.168 mmol) in o-xylene (6, 6.1 ml, 1.01mmol), AlCl3 (1.07 g, 8.02 mmol) was
added on rt. The reaction mixture was stirred 40 min at rt and partitioned between water and EtOAc. The
organic layer was washed with H2O, NaHCO3, and brine, dried over MgSO4, filtered and concentrated. The
residue was purified by column chromatography (EtOAc: hexane = 1: 3) to give light yellow solid L-10 (41.1 mg,
74 %). 1H-NMR (270 MHz, CDCl3) δ: 7.79 (1H, s), 7.75 (1H, d, J 7.9 Hz), 7.55 (1H, br s), 7.28 (1H, d, J 7.9 Hz), 5.75
13
(1H, td, J 7.5, 4.1 Hz), 2.48 (2H, m), 2.34 (6H, s),2.30 (1H, m), 2.04 (3H, s), 1.96 (1H, m). C-NMR (67.8 MHz,
2
1
CDCl3) δ: 196.0, 156.9 (q, JCF 37.6 Hz), 144.6, 137.6, 131.1, 130.3, 129.8, 126.5, 115.7 (q, JCF 288.1 Hz), 53.5,
32.3, 29.8, 20.1, 19.7, 15.40. [α]D +21.0 (c 1.0, CHCl3). HRMS-ESI (m/z) [M+H]+ calcd for C15H19F3NO2S+
334.1083, found 334.1057.
1
Compound D-10 was obtained from D-3 in the same manner as L-10 (73 %). H-NMR (270 MHz, CDCl3) δ: 7.79
(1H, s), 7.75 (1H, d, J 8.2 Hz), 7.56 (1H, br s), 7.28 (1H, d, J 8.2Hz), 5.75 (1H, td, J 7.5, 4.1 Hz), 2.48 (2H, m), 2.34
13
2
(6H, s), 2.04 (3H, s), 1.96 (1H, m). C-NMR (67.8 MHz, CDCl3) δ: 196.0, 157.0 (q, JCF 38.5 Hz), 144.6, 137.7,
1
131.2, 130.3, 129.8, 126.5, 115.7 (q, JCF 290.0 Hz), 53.5, 32.8, 29.8, 20.1, 19.7, 15.4. [α]D -22.0 (c 1.0, CHCl3).
HRMS-ESI (m/z) [M+H]+ calcd for C15H19F3NO2S+ 334.1083, found 334.1074.
(S)-N-(1-(2,4-Dimethylphenyl)-4-(methylthio)-1-oxobutan-2-yl)-2,2,2-trifluoroacetamide (L-11). To TFA-L-
methionine-OSu L-3 (57.5 mg, 0.168 mmol) in m-xylene (7, 6.1 ml, 1.01mmol), AlCl3 (1.07 g, 8.02 mmol) was
added on rt. The reaction mixture was stirred 40 min at rt and partitioned between water and EtOAc. The
organic layer was washed with H2O, NaHCO3, and brine, dried over MgSO4, filtered and concentrated. The
residue was purified by column chromatography (EtOAc: hexane = 1: 3) to give dark green liquid L-11 (43.5 mg,
78 %). 1H-NMR (270 MHz, CDCl3) δ: 7.69 (1H, d, J 8.2 Hz), 7.58 (1H, s), 7.16-7.12 (2H, m), 5.65 (1H, td, J 7.6, 4.3
Hz), 2.52 (3H, s), 2.46 (3H, t, J 7.7 Hz), 2.39 (4H, s), 2.28-2.16 (2H, m), 1.99 (3H, s), 1.92 (2H, dd, J 14.2, 6.3 Hz).
2
1
13C-NMR (CDCl3) δ: 199.0, 157.8 (q, JCF 38.0 Hz), 144.9, 141.4, 134.4, 131.2, 130.3, 127.7, 116.6 (q, JCF 288.8
Hz), 55.8, 33.0, 30.5, 22.4, 22.3, 16.3. [α]D +11.0 (c 1.0, CHCl3). HRMS-ESI (m/z) [M+H]+ calcd for C15H19F3NO2S+
334.1083, found 334.1055.
Page 6
©ARKAT USA, Inc